Search Results
Apr 15, 2026, 08:00 ET PrecisionLife and Ovation ink collaboration agreement to launch GLP-1 stratification LDT and consumer GLP-1 DNA test in H2 2026
and tirzepatide against real-world patient outcomes across independent cohorts over the next six months.The partners intend to bring a consumer DNA test to market to enable individuals to understand their likely personal safety, efficacy, and tolerability profile for GLP-1 drugs to make
More news about: PrecisionLife Ltd
Apr 15, 2026, 08:00 ET MCS Health Expands Senior Leadership to Scale Next-Gen Healthcare Communications Model
joins as Vice President, bringing expertise in leading large-scale consumer campaigns across complex therapeutic categories. She most recently served at dna Communications, where she supported integrated global communications programs and data-driven initiatives, contributing to the development of insight-driven
More news about: MCS Health
Apr 15, 2026, 03:00 ET Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration
generation of nanopore-based sensing technology for faster, information rich, accessible and affordable molecular analysis. The first application is DNA/RNA sequencing and the technology is in development for the analysis of other types of molecule including proteins. The technology is used in more than
More news about: Cepheid and Oxford Nanopore Technologies
Apr 14, 2026, 17:45 ET Partner Therapeutics announces submission of supplemental Biologics License Application (sBLA) to FDA for BIZENGRI® (zenocutuzumab-zbco) in NRG1 Fusion Positive Cholangiocarcinoma and Inclusion in updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)
and NRG1 fusion interactions with HER3, resulting in the suppression of these pathways. Comprehensive molecular testing, notably the combination of tissue-based DNA and RNA next generation sequencing, is essential to identify rare and actionable gene fusions like NRG1.About BIZENGRI (zenocutuzumab-zbco)INDICATIONSBIZENGRI
More news about: Partner Therapeutics, Inc.
Apr 14, 2026, 17:00 ET MEDIA ADVISORY - MDA SPACE TO HOLD ITS FIRST QUARTER 2026 EARNINGS CONFERENCE CALL AND ANNUAL MEETING OF SHAREHOLDERS ON MAY 7, 2026
vision into an achievable mission – bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Apr 14, 2026, 13:05 ET AACR annual meeting highlights St. Jude research, honors Comprehensive Cancer Center director
Center, Roberts leads research in the field of cancer epigenetics. He studies how chromatin remodeling complexes, which normally allow access to DNA so genes can be transcribed, contribute to cancer when their normal function is disrupted. His work has led to new FDA-approved and investigational cancer
More news about: St. Jude Children's Research Hospital
Apr 14, 2026, 13:00 ET onX and MeatEater Join Three Rivers Land Trust to Save 4,000 Acres on the Tuckertown Reservoir
outdoor enthusiasts navigate land ownership, access points, and terrain across the United States. Because outdoor adventure is part of the company's DNA, onX believes everyone should have access to nature and the recreation it provides. Since 2018, onX has worked with partners to secure and improve public
More news about: onX
Apr 14, 2026, 10:17 ET CSF Liquid Biopsy May Help Clarify Inconclusive Leptomeningeal Disease Cases, Study Finds
Diagnostics suggests that a standard lumbar puncture may help address this diagnostic gap. By measuring variant allele frequency (VAF) in tumor-derived DNA from CSF using the Summit™ liquid biopsy assay, clinicians gain specific, quantitative signals to support diagnosis and monitor treatment response over
More news about: Belay Diagnostics
Apr 14, 2026, 09:15 ET Illumina and the Center for Data-Driven Discovery in Biomedicine bring genomic data and scalable software to the fight against pediatric cancer and rare disease
IlluminaIllumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in
More news about: Illumina, Inc.
Apr 14, 2026, 09:00 ET Co-Diagnostics to Showcase Co-Dx PCR Platform and CE-IVD Solutions at ESCMID 2026 in Munich, Germany
diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to
More news about: Co-Diagnostics
Apr 14, 2026, 09:00 ET 5th Century Partners Promotes Will Smith to Partner
value realization. Our mandate remains clear and unchanged: maximize value for our investors and partners, move with urgency, and preserve the founder DNA that makes these businesses so special."Smith brings more than 25 years of operating experience with a strong track record of growth, M&A,
More news about: 5th Century Partners
Apr 14, 2026, 08:38 ET Karo-Lynn Reyes Releases Encoded in Light: The Path of DNA, Soul Memory, and Earth's Ascension
Encoded in Light: The Path of DNA, Soul Memory, and Earth's Ascension, available in hardcover beginning Tuesday, April 14, 2026.
More news about: Dimensional Clarity
Apr 14, 2026, 08:37 ET Astreya Launches AI OpsHub: The Industry's First Operational Brain for Hybrid IT
productivity; it is about institutional resilience," says Edward Betancourt, Chief Technology Officer (CTO), Astreya. "By digitizing the operational DNA of IT, we enable organizations to scale workloads without proportionally scaling headcount, aligning execution with the efficiency expectations set at
More news about: Astreya
Apr 14, 2026, 07:25 ET CHARBONE Unveils its 2026-2030 Strategic Plan: A Transformation Towards an Integrated High-Value Industrial Gas Group
defense technologies.These markets demand impeccable quality, speed of execution, and security of supply; pillars at the heart of CHARBONE's DNA.A Two-Pillar Strategy in North AmericaGrowth will be based on a structured hybrid approach:Pillar A –
More news about: CHARBONE Corporation
Apr 13, 2026, 20:00 ET Kelun-Biotech Announces Results from the SKB264-II-06/MK-2870-002 Study of Sacituzumab Tirumotecan (Sac-TMT) in Gynecologic Oncology Presented at 2026 SGO
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Kelun-Biotech
Apr 13, 2026, 18:16 ET JiYu Skin Announces Expansion into Longevity Skincare, Positioning as a Leading Korean Skincare Brand in the U.S. Market
category will increasingly require."Korean formulation science has always been built around long-term skin health — that philosophy is in the DNA of how we develop every product. What JiYu is doing is bringing that depth of formulation to the longevity conversation happening in the West. No one
More news about: JiYu Skin
Apr 13, 2026, 14:10 ET WARNER MUSIC GROUP ANNOUNCES STRATEGIC INVESTMENT AND EXPANSIVE PARTNERSHIP WITH TUSTREAMS
incredible roster that Tony and his team have built and plugging it into our worldwide distribution and marketing network. By combining TuStreams' creative DNA and unmatched ability to identify the next generation of hitmakers with the global scale and long-term artist development expertise of Warner Music Group,
More news about: Warner Music Group Corp.
Apr 13, 2026, 10:09 ET CGTN AMERICA a CCTV OSN: Oslava Dňa čínskeho jazyka v OSN v rámci podujatia „Žiariace civilizácie čínskeho jazyka"
príležitosti „Oslavy Dňa čínskeho jazyka v OSN pod názvom ‚Žiariace civilizácie čínskeho jazyka'" (Tento materiál distribuuje MediaLinks TV, LLC v mene CCTV. Ďalšie informácie sú k dispozícii na ministerstve spravodlivosti, Washington, D.C.)Pri príležitosti 17. ročníka Dňa čínskeho jazyka v
More news about: MediaLinks TV LLC
Apr 13, 2026, 09:23 ET Khoros lanza Aurora AI: Un nuevo amanecer para la comunidad empresarial
ha transformado por completo en una empresa AI-DNA, no añadimos IA a software heredado", afirmó Eric Vaughan, consejero delegado de IgniteTech y Khoros. "Reconstruimos los productos de Khoros
More news about: Khoros, LLC
Apr 13, 2026, 09:00 ET Aura Expands into Enterprise Security with Industry Leading, Identity-Centric BYOD Offering
with identity-based security compromises, such as phishing, social engineering and credential misuse.1"Identity protection is in our DNA. Aura has spent years building AI-powered, all-in-one online protection for the whole family, and as identity-based risk grows in the enterprise, the
More news about: Aura
Apr 13, 2026, 03:52 ET MGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents
a single ecosystem. This integration enables researchers to capture biological information across multiple dimensions:DNA — decoding the genetic blueprint of lifeCell Omics — analyzing biological processes at single-cell resolutionSpatial Omics — mapping
More news about: MGI TECH
Apr 13, 2026, 03:06 ET MARLI NEW YORK INTRODUCES MOTION AND MEASURE: AN EVOLUTION INTO TIMEPIECES
GENEVA, April 13, 2026 /PRNewswire/ -- MARLI New York, the fine jewelry brand defined by its architectural DNA and modern energy, announces its official expansion into watchmaking with the debut of MARLI Timepieces. Under the guiding philosophy of Motion and Measure,
More news about: MARLI
Apr 13, 2026, 00:00 ET MDA SPACE UNVEILS SPACE CONTROL PLATFORM MDA MIDNIGHT™, DESIGNED TO DEFEND AND PROTECT THE SPACE DOMAIN
vision into an achievable mission—bringing to bear a one-of-a-kind mix of experience, engineering excellence and wide-eyed wonder that's been in our DNA since day one. For those who dream big and push boundaries on the ground and in the stars to change the world for the better, we'll take you there. For
More news about: MDA Space
Apr 11, 2026, 16:21 ET Khoros bringt Iris® AI auf den Markt: Ihr Messenger über alle Markenkanäle hinweg
vollständig zu einem Unternehmen mit KI-DNA gewandelt haben, ist es uns gelungen, die über 15 Jahre hinweg in verschiedenen Produkten angehäuften technischen Altlasten in weniger als einem
More news about: Khoros, LLC
Apr 11, 2026, 16:16 ET Khoros führt Aurora AI ein: Eine neue Ära für Unternehmens-Communities
vollständig zu einem Unternehmen mit KI-DNA gewandelt hat, haben wir KI nicht einfach an unsere bestehende Software angehängt", sagte Eric Vaughan, Geschäftsführer von IgniteTech und Khoros.
More news about: Khoros, LLC